SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-146381
Filing Date
2016-09-26
Accepted
2016-09-26 06:04:21
Documents
3
Period of Report
2016-09-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-18896_18k.htm 8-K 21066
2 EX-99.1 a16-18896_1ex99d1.htm EX-99.1 19232
3 GRAPHIC g188961moi001.jpg GRAPHIC 6848
  Complete submission text file 0001104659-16-146381.txt   50984
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 161901120
SIC: 2834 Pharmaceutical Preparations